Freiburg, Germany

Ansgar Boegershausen

This inventor holds 1 USPTO granted patent. Top assignee: Dr. Falk Pharma Gmbh. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ansgar Boegershausen. Retrieved from https://idiyas.com/inventor/ansgar-boegershausen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ansgar Boegershausen: Innovator in Pharmaceutical Formulations

Introduction

Ansgar Boegershausen, based in Freiburg, Germany, is an accomplished inventor recognized for his innovative contributions to the field of pharmaceutical formulations. His pioneering work focuses on enhancing drug delivery, particularly for the treatment of inflammatory diseases of the colon.

Latest Patents

Boegershausen holds a notable patent titled "Pellets having a multi-layer structure for delayed release of the active substance in the distal colon." This optimized pharmaceutical formulation comprises a capsule containing pellets designed for oral administration. The unique multi-layer structure allows for targeted release of the active substance specifically in the colon, ensuring maximum efficacy while maintaining low blood plasma levels. The formulation stands out for its excellent medicinal safety profile, supported by extensive pharmacokinetic and clinical studies demonstrating its effectiveness.

Career Highlights

Ansgar Boegershausen is currently affiliated with Dr. Falk Pharma GmbH, a company that specializes in developing innovative pharmaceutical solutions. His work at Dr. Falk Pharma emphasizes a commitment to improving therapeutic outcomes for patients suffering from various inflammatory conditions.

Collaborations

Throughout his career, Boegershausen has collaborated with esteemed colleagues such as Rudolf Wilhelm and Markus Proels, combining their expertise to advance the research and development of effective pharmaceutical formulations. These collaborations have played a significant role in refining the quality and safety of their innovative products.

Conclusion

Ansgar Boegershausen stands out as a key inventor in the pharmaceutical industry, making substantial contributions to the development of targeted drug delivery systems. His dedication to innovation, combined with collaborative efforts, continues to drive advancements in the treatment of inflammatory diseases of the colon. Through his work, Boegershausen exemplifies the critical role inventors play in enhancing patient care and health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…